Anticorps Polyclonal de lapin anti-SARS-CoV-2 S protein (944-1214 aa)

SARS-CoV-2 S protein (944-1214 aa) Polyclonal Antibody for ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Virus et plus (4)

Applications

WB, IHC, IF, ELISA

Conjugaison

Non conjugué

N° de cat : 28867-1-AP

Synonymes

S protein, SARS-CoV-2 Spike Glycoprotein (944-1214 aa), spike, spike protein



Applications testées

Résultats positifs en ELISAProtéine recombinante

Dilution recommandée

ApplicationDilution
Test immuno-enzymatique (ELISA)ELISA :
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Informations sur le produit

28867-1-AP cible SARS-CoV-2 S protein (944-1214 aa) dans les applications de WB, IHC, IF, ELISA et montre une réactivité avec des échantillons Virus

Réactivité Virus
Réactivité citéeHumain, singe, souris, Hamster
Hôte / Isotype Lapin / IgG
Clonalité Polyclonal
Type Anticorps
Immunogène SARS-CoV-2 S protein (944-1214 aa) Protéine recombinante Ag30685
Nom complet SARS-CoV-2 Spike Protein
Masse moléculaire calculée 141 kDa
Numéro d’acquisition GenBankNC_045512
Symbole du gène COVID-19 S Protein
Identification du gène (NCBI) 43740568
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par affinité contre l'antigène
Tampon de stockage PBS avec azoture de sodium à 0,02 % et glycérol à 50 % pH 7,3
Conditions de stockageStocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA.

Informations générales

Coronaviruses (CoVs) infect human and animals and cause varieties of diseases, including respiratory, enteric, renal, and neurological diseases. CoV uses its spike protein to recognize ACE2 as its receptors and mediate membrane fusion and virus entry into host cells(PMID: 32221306). Each monomer of trimeric S protein is about 180 kDa, and contains two subunits, S1 and S2,S1 recognizes and binds to host receptors, and subsequent conformational changes in S2 facilitate fusion between the viral envelope and the host cell membrane(PMID: 19198616). Although the amino acid sequences of the S-glycoprotein were found to be different between the various HCoV, the structures showed high similarity, but the best 3D structural overlap shared by SARS-CoV and SARS-CoV-2, consistent with the shared ACE2 predicted receptor (PMID: 32522207). The spike protein of CoVs can be a target for vaccine and therapeutic development (PMID: 19198616). This antibody detects the spike protein of SARS and SARS-COV-2.

Publications

SpeciesApplicationTitle
monkey,hamsterIF

Nat Biomed Eng

High-throughput screening of genetic and cellular drivers of syncytium formation induced by the spike protein of SARS-CoV-2

Authors - Charles W F Chan
humanIF

Nat Immunol

Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules.

Authors - Matteo Stravalaci
IF

Cell Rep

Diverse immunoglobulin gene usage and convergent epitope targeting in neutralizing antibody responses to SARS-CoV-2.

Authors - Xiaojuan Zhou
IF

Pathogens

Hydrophobic Alpha-Helical Short Peptides in Overlapping Reading Frames of the Coronavirus Genome

Authors - Takashi Okura
mouseIHC,WB

Nat Commun

Essential role of TMPRSS2 in SARS-CoV-2 infection in murine airways

Authors - Naoko Iwata-Yoshikawa
humanIF

Int J Mol Sci

Modulation of NBAS-Related Functions in the Early Response to SARS-CoV-2 Infection

Authors - Valentina Granata